Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6537
    +0.0013 (+0.20%)
     
  • OIL

    84.05
    +0.48 (+0.57%)
     
  • GOLD

    2,357.30
    +14.80 (+0.63%)
     
  • Bitcoin AUD

    98,251.77
    +560.39 (+0.57%)
     
  • CMC Crypto 200

    1,384.85
    -11.68 (-0.84%)
     
  • AUD/EUR

    0.6097
    +0.0023 (+0.39%)
     
  • AUD/NZD

    1.0985
    +0.0028 (+0.25%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,116.74
    +37.88 (+0.47%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    18,050.46
    +133.18 (+0.74%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

2 Growth Stocks Down 14% to 28% to Buy and Hold Forever

2 Growth Stocks Down 14% to 28% to Buy and Hold Forever

Let's examine two stocks worth keeping in this challenging market and beyond: Abbott Laboratories (NYSE: ABT) and Apple (NASDAQ: AAPL). Abbott Laboratories focuses on medical devices, although it has a diversified business with multiple segments that allow it to navigate difficult times. For instance, when the company's medical devices segment took a hit during the pandemic, its diagnostics unit picked up the slack.